Pharma News
-
China's first pre-exposure prevention drug approved for HIV
The approval of Sufatai's PrEP indication is based on two randomized, double-blind, placebo-controlled clinical trials, namely the iPrEx trial and the partner PrEP trial. Among them, the iPrEx test enrolled 2,499 HIV seronegative men or transgender women
-
Russia registers the world's first new covid-19 vaccine
Vladimir Putin has approved the world's first new crown pneumonia vaccine developed by Russia.
-
Nearly ten Chinese API companies increase capital and expand production
With the increase in the importance of APIs, the battle for the market has intensified. According to endless statistics, since the beginning of this year, nearly ten API companies have increased their capital and expanded production.
-
Acetaminophen poisoning? New synthetic oligosaccharides to help
Heparan sulfate is widely present on the surface of all mammalian cells and interacts with a variety of important proteins. Therefore, drugs that target the interaction of heparan sulfate with proteins can essentially block signal transduction more effect
-
Global 500 pharmaceutical companies released
The most eye-catching change this year is undoubtedly the historic leapfrogging of mainland Chinese companies: the number of mainland Chinese (including Hong Kong) companies reached 124, surpassing the United States (121) for the first time in history
-
How likely is the localization of Indian and American APIs?
Statistics of import and export goods released by the General Administration of Customs of China show that my country exported 5,446,100 tons of APIs to Asia last year. Asia has become my country's largest export market for APIs
-
The EU issued a formal ban on lambda-cyfluthrin
According to the announcement, the relevant preparation products should be withdrawn from the market within 6 months of the effective date of the announcement. Each member state can grant a grace period of 6 months, and the authorization of all products
-
Speed up consistency evaluation in 2020? Injection is the main force
Since the outbreak of COVID-19 epidemic in February, the consistency evaluation work has been carried out, but the number of acceptance cases decreased sharply in March and April, less than half of the total amount in February.
-
Nine kinds of drugs or meet the outbreak!
Among them, the long-term prescription drug list covers 137 varieties, and is divided into 9 categories of drugs, including hypertension, diabetes, dyslipidemia, COPD, chronic kidney, stroke, chronic prostate, chronic heart failure, and other commonly use
-
Locking down shape-shifting spike protein aids development of COVID-19 vaccine
The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein.
-
Pfizer signs deal to manufacture Gilead's remdesivir
Pfizer Inc said on Friday it signed a multi-year agreement to manufacture Gilead Sciences Inc’s antiviral drug remdesivir for COVID-19 patients in a bid to ramp up its supply.
Hot News
Echemi Partner
